arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

download Export Data

AVAI BIO, INC.

AVAI

— Price unavailable

8 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

AVAI BIO, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin None

ROIC 49.1% ↘

FCF / Share $-0.01 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-1.75M

↓ -53.2% —

FCF / Share Free cash flow per share

$-0.01

↑ +19.2% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2022 10-K ↗	FY 2022 Mar 31, 2021 10-K ↗	FY 2021 Mar 31, 2020 10-K ↗	FY 2020 Mar 31, 2019 10-K ↗	FY 2019 Mar 31, 2018 10-K ↗
EPS Growth YoY (%)	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-53.2% Weak ↑ Weak Improving Year-over-year change in net income	-227.3% Weak ↓ Weak Declining Year-over-year change in net income	-175.8% Weak ↓ Weak Declining Year-over-year change in net income	58.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-334.4% Weak Weak Year-over-year change in net income	11.0% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	19.2% Good ↓ Good Declining Year-over-year change in free cash flow	-540.4% Weak Weak Year-over-year change in free cash flow	N/M	2214.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2022 10-K ↗	FY 2022 Mar 31, 2021 10-K ↗	FY 2021 Mar 31, 2020 10-K ↗	FY 2020 Mar 31, 2019 10-K ↗	FY 2019 Mar 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	-126.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-731%)	—	—	—	—	—
Profit Margin (%) (%)	—	—	-126.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-942%)	—	—	—	—	—
FCF Margin (%) (%)	—	—	-19.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	0.58x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-4.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.08x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.88x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2022 10-K ↗	FY 2022 Mar 31, 2021 10-K ↗	FY 2021 Mar 31, 2020 10-K ↗	FY 2020 Mar 31, 2019 10-K ↗	FY 2019 Mar 31, 2018 10-K ↗
Return on Invested Capital (%)	49.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	57.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	43.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-72.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	145.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	124.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-305.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-508.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-144.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	27.8% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	37.0% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-16.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-256.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	62.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+236%)	73.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+295%)	55.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+198%)	31.2% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+69%)	92.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+399%)	184.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+898%)	157.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+752%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2022 10-K ↗	FY 2022 Mar 31, 2021 10-K ↗	FY 2021 Mar 31, 2020 10-K ↗	FY 2020 Mar 31, 2019 10-K ↗	FY 2019 Mar 31, 2018 10-K ↗
Net Debt (USD)	$-23.14K	$-81.05K	$-107.47K	$-33.29K	$-60.36K	$-27.30K	$-102.00	—

📊 What does each share earn? 6 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2022 10-K ↗	FY 2022 Mar 31, 2021 10-K ↗	FY 2021 Mar 31, 2020 10-K ↗	FY 2020 Mar 31, 2019 10-K ↗	FY 2019 Mar 31, 2018 10-K ↗
Revenue per Share (USD)	—	—	$0.01	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.01	$-0.01	$0.00	$0.00	$0.00	—	—	—
Free Cash Flow per Share (USD)	$-0.01	$-0.01	$-0.00	$0.02	$0.00	—	—	—
Book Value per Share (USD)	$-0.02	$-0.01	$-0.02	$-0.02	$-0.01	$-0.04	$-0.01	$0.00
Tangible Book Value per Share (USD)	$-0.02	$-0.01	$-0.02	$-0.02	$-0.01	$-0.24	$-0.01	$0.00
Basic Weighted Avg Shares (shares)	137.97M	128.15M	38.50M	26.32M	26.28M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2022 10-K ↗	FY 2022 Mar 31, 2021 10-K ↗	FY 2021 Mar 31, 2020 10-K ↗	FY 2020 Mar 31, 2019 10-K ↗	FY 2019 Mar 31, 2018 10-K ↗
Working Capital (USD)	$-3.30M	$-1.70M	$-767.14K	$-529.35K	$-523.39K	$-271.61K	$-5.06K	$641.00
Total Equity (USD)	$-2.82M	$-1.56M	$-633.26K	$-405.56K	$-327.41K	$-37.69K	$-49.61K	$0.00

📋 What is driving earnings? 4 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2022 10-K ↗	FY 2022 Mar 31, 2021 10-K ↗	FY 2021 Mar 31, 2020 10-K ↗	FY 2020 Mar 31, 2019 10-K ↗	FY 2019 Mar 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	$276.32K	—	—	—	—	—
Depreciation Expense (USD)	$26.07K	$74.32K	$23.42K	—	—	$36.94K	$4.80K	—
Net Income, GAAP (USD)	$-1.75M	$-1.14M	$-348.93K	$-126.52K	$-302.29K	$-69.59K	$-78.22K	—
Operating Cash Flow (USD)	$-1.01M	$-1.16M	$-54.46K	$535.01K	$23.09K	$130.72K	$-84.17K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters

AVAI BIO, INC.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AVAI with peers